Epigenetic therapy in allogeneic hematopoietic stem cell transplantation

by Bashir, Qaiser, William, Basem Magdy, Garcia-Manero, Guillermo, de Lima, Marcos
Published 2013

FIFTY YEARS OF MELPHALAN USE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

by Bayraktar, Ulas D., Bashir, Qaiser, Qazilbash, Muzaffar, Champlin, Richard E., Ciurea, Stefan O.
Published in Biol Blood Marrow Transplant (2012)

Review of Haploidentical Hematopoietic Cell Transplantation

by Khan, Mehreen A., Bashir, Qaiser, Chaudhry, Qamar-un-Nisa, Ahmed, Parvez, Satti, Tariq M., Mahmood, Syed K.
Published in J Glob Oncol (2018)

Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells

by Valdez, Benigno C., Li, Yang, Murray, David, Liu, Yan, Nieto, Yago, Bashir, Qaiser, Qazilbash, Muzaffar H., Andersson, Borje S.
Published in Exp Hematol (2020)

Chromosome 8q24.1/c-MYC Abnormality: A Marker for High-Risk Myeloma

by Glitza, Isabella C., Lu, Gary, Shah, Rupin, Bashir, Qaiser, Shah, Nina, Champlin, Richard E., Shah, Jatin, Orlowski, Robert Z., Qazilbash, Muzaffar H.
Published in Leuk Lymphoma (2014)

Durable Responses with Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) in Patients with POEMS Syndrome

by Patel, Krina, Nusrat, Maliha, Shah, Nina, Bashir, Qaiser, Parmar, Simrit, Shah, Jatin, Thomas, Sheeba, Weber, Donna, Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar H
Published 2014

Durable Remission With Salvage Second Autotransplants in Patients with Multiple Myeloma

by Shah, Nina, Ahmed, Fraz, Bashir, Qaiser, Qureshi, Sofia, Dinh, Yvonne, Rondon, Gabriela, Wen, Sijin, Thall, Peter, Khan, Hassan, Giralt, Sergio, Champlin, Richard, Qazilbash, Muzaffar H.
Published 2011

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma

by Badar, Talha, Srour, Samer, Bashir, Qaiser, Shah, Nina, Al-Atrash, Gheath, Hosing, Chitra, Popat, Uday, Nieto, Yago, Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar H.
Published in Eur J Haematol (2016)

Age and number of apheresis days may predict for development of Secondary Myelodysplastic Syndrome and Acute Myelogenous Leukemia after transplantation for lymphomas

by Ge, Isabell, Saliba, Rima M, Maadani, Farzaneh, Popat, Uday R, Qazilbash, Muzaffar H., Pingali, Sai Ravi, Shah, Nina, Ahmed, Sairah, Bashir, Qaiser, Nieto, Yago, Champlin, Richard E, Hosing, Chitra M.
Published in Transfusion (2017)

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplantation

by Bashir, Qaiser, Munsell, Mark F, Giralt, Sergio, de Padua Silva, Leandro, Sharma, Manish, Couriel, Daniel, Chiattone, Alexandre, Popat, Uday, Qazilbash, Muzaffar H, Fernandez-Vina, Marcelo, Champlin, Richard E, de Lima, Marcos J
Published 2011

Higher stem cell dose infusion after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis

by Shah, Nina, Shi, Qiuling, Williams, Loretta A., Mendoza, Tito R., Wang, Xin Shelley, Reuben, James M., Dougherty, Patrick M., Bashir, Qaiser, Qazilbash, Muzaffar H., Champlin, Richard E., Cleeland, Charles S., Giralt, Sergio A.
Published in Biol Blood Marrow Transplant (2015)

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

by Maymani, Hossein, Lin, Paul, Saliba, Rima M., Popat, Uday, Bashir, Qaiser, Shah, Nina, Patel, Krina, Parmar, Simrit, Kebriaei, Partow, Hosing, Chitra, Ciurea, Stefan, Andersson, Borje, Shpall, Elizabeth, Champlin, Richard, Qazilbash, Muzaffar H.
Published in Biol Blood Marrow Transplant (2019)

Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients

by El Fakih, Riad, Fox, Patricia, Popat, Uday, Nieto, Yago, Shah, Nina, Parmar, Simrit, Oran, Betul, Ciurea, Stephan, Kebriaei, Partow, Hosing, Chitra, Ahmed, Sairah, Shah, Jatin, Orlowski, Robert, Champlin, Richard, Qazilbash, Muzaffar, Bashir, Qaiser
Published in Clin Lymphoma Myeloma Leuk (2015)

Minimal residual disease negativity does not overcome poor prognosis in high risk multiple myeloma: a single center retrospective study

by Kunacheewa, Chutima, Lee, Hans C., Patel, Krina, Thomas, Sheeba, Behrang, Amini, Srour, Samer, Bashir, Qaiser, Nieto, Yago, Qazilbash, Muzzaffar H., Weber, Donna M., Feng, Lei, Orlowski, Robert Z., Lin, Pei, Manasanch, Elisabet E.
Published in Clin Lymphoma Myeloma Leuk (2020)

Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission

by Bashir, Qaiser, Andersson, Borje S., Fernandez-Vina, Marcelo, de Padua Silva, Leandro, Giralt, Sergio, Chiattone, Alexandre, Wei, Wei, Sharma, Manish, Anderlini, Paolo, Shpall, Elizabeth J., Popat, Uday, Rodrigues, Morgani, Champlin, Richard E., de Lima, Marcos
Published 2010

Significance of Persistent Cytogenetic Abnormalities at Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission

by Oran, Betul, Popat, Uday, Rondon, Gabriella, Ravandi, Farhad, Garcia-Manero, Guillermo, Abruzzo, Lynn, Andersson, Borje S., Bashir, Qaiser, Chen, Julianne, Kebriaei, Partow, Khouri, Issa F., Koca, Ebru, Qazilbash, Muzaffar H., Champlin, Richard, de Lima, Marcos
Published 2012

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

by Ciurea, Stefan O., Kongtim, Piyanuch, Varma, Ankur, Rondon, Gabriela, Chen, Julianne, Srour, Samer, Bashir, Qaiser, Alousi, Amin, Mehta, Rohtesh, Oran, Betul, Popat, Uday, Hosing, Chitra, Olson, Amanda, Daver, Naval, Konopleva, Marina, Champlin, Richard E.
Published in Blood (2020)

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

by Mehta, Rohtesh S., Saliba, Rima M., Chen, Julianne, Rondon, Gabriela, Hammerstrom, Aimee E., Alousi, Amin, Qazilbash, Muzaffar, Bashir, Qaiser, Ahmed, Sairah, Popat, Uday, Hosing, Chitra, Khouri, Issa, Shpall, Elizabeth J., Champlin, Richard E., Ciurea, Stefan O.
Published in Br J Haematol (2016)

Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib

by Sharma, Manish, Ravandi, Farhad, Bayraktar, Ulas Darda, Chiattone, Alexandre, Bashir, Qaiser, Giralt, Sergio, Chen, Julianne, Qazilbash, Muzaffar, Kebriaei, Partow, Konopleva, Marina, Andreeff, Michael, Cortes, Jorge, McCue, Deborah, Kantarjian, Hagop, Champlin, Richard E., de Lima, Marcos
Published 2011

Impact Of t(11;14)(q13;q32) On The Outcome Of Autologous Hematopoietic Cell Transplantation In Multiple Myeloma

by Sasaki, Koji, Lu, Gary, Saliba, Rima M., Bashir, Qaiser, Hosing, Chitra, Popat, Uday, Shah, Nina, Parmar, Simrit, Dinh, Yvonne, Ahmed, Sairah, Shpall, Elizabeth J., Kebriaei, Partow, Shah, Jatin J., Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar H.
Published 2013